MedTrace Logo

Written Genetic Counseling and Mutation Analysis of BRCA1 and BRCA2 to Patients With Breast Cancer

NCT02557776 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 542

Last updated 2019-02-06

No results posted yet for this study

Summary

The overall purpose of the study is to evaluate a method for offering mutation analysis of BRCA1 and BRCA2 to all patients with newly diagnosed breast cancer, regardless of age at diagnosis and family history. Information about the study as well as pre-test genetic counseling will primarily be given in a written way. In addition to that, if a study participant wishes to, she can also receive pre-test telephone genetic counseling.

Conditions

  • Hereditary Breast Cancer

Interventions

GENETIC

Germline genetic testing of BRCA1 and BRCA2

Sponsors & Collaborators

  • Lund University

    lead OTHER

Principal Investigators

  • Niklas Loman, MD, PhD · Head of Section for Breast Cancer, Melanoma and CNS tumors. Dept of Oncology, Skane University Hospital, Lund, Sweden

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02557776 on ClinicalTrials.gov